Jan C. Drooger

A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy‐free approach in HER2‐positive metastatic breast cancer: The HAT study (BOOG 2008‐2003), a Dutch Breast Cancer Research Group trial

S. Sleijfer, A. Jager, S. Linn, 2016, Cancer.